Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

How State SG Offices Became A Judicial Pipeline No Photo Available

The rapid growth of Missouri's solicitor general's office illustrates the import of top state appellate roles, which offer young lawye... (more story)

Voluntary Benefits Suits Emerge As New ERISA Battleground No Photo Available

A recent crop of proposed class actions targeting employers' insurance-related voluntary benefits offerings — for things like critical... (more story)

J&J $5.5B Talc MDL Deal, $25.4M Cooley Judgment And More No Photo Available

Law360 Healthcare Authority looks at Johnson & Johnson's $5.5 billion commitment in a proposed settlement to resolve thousands of suit... (more story)